Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-04 5:23 pm Purchase | 2025-11-01 | 13D | NewAmsterdam Pharma Company N.V. NAMS | Frazier Life Sciences X, L.P. | 8,623,939 7.700% | 1,296,002 (+17.69%) | Filing History |
| 2025-08-20 5:28 pm Sale | 2025-08-18 | 13D | NewAmsterdam Pharma Company N.V. NAMS | Frazier Life Sciences X, L.P. | 7,327,937 6.500% | -9,088,814 (-55.36%) | Filing History |
| 2024-12-17 10:28 am Purchase | 2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS | Frazier Life Sciences X, L.P. | 16,416,751 15.300% | 3,784,713 (+29.96%) | Filing History |
| 2024-02-21 11:11 am Purchase | 2024-02-16 | 13D | NewAmsterdam Pharma Company N.V. NAMS | Frazier Life Sciences X, L.P. | 12,632,038 14.200% | 1,485,807 (+13.33%) | Filing History |
| 2023-08-15 4:02 pm Purchase | 2023-08-11 | 13D | NewAmsterdam Pharma Company N.V. NAMSW | Frazier Life Sciences X, L.P. | 12,632,038 15.300% | 12,632,038 (New Position) | Filing History |
| 2023-06-09 3:47 pm Purchase | 2023-06-07 | 13D | NewAmsterdam Pharma Company N.V. NAMS | Frazier Life Sciences X, L.P. | 11,146,231 13.500% | 11,146,231 (New Position) | Filing History |